Search Results 611-620 of 17342 for Proto-oncogene
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers. ROCHESTER, ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Participants provide their family health history for the conditions studied in the eMERGE phase 4 study. To do this, they use the online MeTree tool created ...
Center for Computational Biotechnology and Genomic Medicine CCBGM.
This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate cancer after ...
Evaluation of quantitative biomarkers derived from simultaneous time-of-flight FDG PET-MRI/MRCP for assessment of response to neoadjuvant therapy in borderline ...
Perry LM, Kleber KT, Rajasekar G, Nuño M, Bold RJ. The Impact of Preexisting Psychiatric Disorders on Outcomes After Pancreatic Cancer Surgery. Pancreas. 2022 ...
About this study. Part A: (ADXS11-001 + MEDI4736 Combination Therapy) will determine the safety and tolerability of the combination and to identify a RP2D.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.